NUCRYST Pharmaceuticals Corp. Appoints Katherine J. Turner, Ph.D. Vice President Of Research

WAKEFIELD, MA, June 13 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST - News; TSX: NCS - News) is pleased to announce that Katherine J. Turner, Ph.D. has been appointed Vice President of Research.

MORE ON THIS TOPIC